Effect of transient expression of the oestrogen receptor on constitutive and inducible CYP1A1 in Hs578T human breast cancer cells

British Journal of Cancer

Volumn 73, Issue 3, 1996, Pages 316-322

  Wang, W L ^a   Thomsen, J S ^a   Porter, W ^a   Moore, M ^a   Safe, S ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

CYP1A1; Oestrogen receptor

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON; CHLORAMPHENICOL ACETYLTRANSFERASE; ESTROGEN RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CANCER; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030043650     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.55     Document Type: Article

References (52)

1. ANTTILA S, HIETANEN E, VAINIO H, CAMUS A, GELBOIN HV, PARK SS, HEIKKILA L, KARJALAINEN A AND BARTSCH H. (1991). Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P4501A in lung cancer patients. Int. J. Cancer, 47, 681-685.
2. ARELLANO LO, WANG X AND SAFE S. (1993). Effects of cycloheximide on the induction of CYP1A1 gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in three human breast cancer cell lines. Carcinogenesis, 14, 219-222.
3. BOUCHER PD, RUCH RJ AND HINES RN. (1993). Specific nuclear protein binding to a negative regulatory element on the human CYP1A1 gene. J. Biol. Chem., 268, 17384-17391.
4. BRADFORD MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
5. BURBACH KM, POLAND AB AND BRADFIELD CA. (1992). Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl Acad. Sci. USA, 89, 8185-8189.
6. CHALOUPKA K, STEINBERG M, SANTOSTEFANO M, RODRIGUEZ LV, GOLDSTEIN L AND SAFE S. (1995). Induction of Cyp1a-1 and Cyp1a-2 gene expression by a reconstituted mixture of polynuclear aromatic hydrocarbons in B6C3F1 mice. Chem.-Biol., Interact., 96, 207-221.
7. DAFFADA AAI, JOHNSTON SRD, SMITH IE, DETRE S, KING N AND DOWSETT M. (1995). Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer. Cancer Res., 55, 288-293.
8. DENISON MS AND DEAL RM. (1990). The binding of transformed aromatic hydrocarbon (Ah) receptor to its DNA recognition site is not affected by metal depletion. Mol. Cell Endocrinol., 69, 51-57.
9. EMA M, SOGAWA K, WATANABE N, CHUJOH Y, MATSUSHITA N, GOTOH O, FUNAE Y AND FUJII-KURIYAMA Y. (1992). cDNA cloning and structure of the putative Ah receptor. Biochem. Biophys. Res. Comm., 184, 246-253.
10. FOLDES RL AND BRESNICK E. (1989). Inducibility of rat liver cytochrome P-450IA1 (P-450c) mRNA during the partial inhibition of protein synthesis. Biochem. Pharmacol., 38, 1017-1019.
11. FUJISAWA-SEHARA A, SOGAWA K, YAMANE M AND FUJII-KURIYAMA Y. (1987). Characterization of xenobiotic responsive elements upstream from the drug-metabolizing cytochrome P-450c gene: a similarity to glucocorticoid regulatory elements. Nucleic Acids Res., 15, 4179-4191.
12. FUQUA SAW, ALLRED DC AND AUCHUS RJ. (1993). Expression of estrogen receptor variants. J. Cell. Biochem., 17G, 194-197.
13. 1-450 gene. Nucleic Acids Res., 13, 7269-7288.
14. GRADIN K, WILHELMSSON A, POELLINGER L AND BERGHARD A. (1993). Nonresponsiveness of normal fibroblasts to dioxin correlates with the presence of a constitutive xenobiotic response element-binding factor. J. Biol. Chem., 268, 4061-4068.
15. HARRIS M, PISKORSKA-PLISZCZYNSKA J, ZACHAREWSKI T, ROMKES M AND SAFE S. (1989). Structure-dependent induction of aryl hydrocarbon hydroxylase in human breast cancer cell lines and characterization of the Ah receptor. Cancer Res., 49, 4531-4535.
16. HINES RN, MATHIS JM AND JACOB CS. (1988). Identification of multiple regulatory elements on the human cytochrome P4501A1 gene. Carcinogenesis, 9, 1599-1605.
17. HOFFMAN EC, REYES H, CHU F, SANDER F, CONLEY LH, BROOKS BA AND HANKINSON O. (1991). Cloning of a factor required for activity of the Ah (dioxin) receptor. Science, 252, 954-958.
18. IVY SP, TULPULE A, FAIRCHILD CR, AVERBUCH SD, MYERS CE, NEBERT DW, BAIRD WM AND COWAN KH. (1988). Altered regulation of P-4501A1 expression in a multidrug-resistant MCF-7 human breast cancer cell line. J. Biol. Chem., 263, 19119-19125.
19. 1-450: complementary DNA and amino acid sequence. Science, 228, 80-83.
20. 1-450 gene expression by dioxin. Science, 227, 1499-1502.
21. 1-450 gene expression: analysis of a dioxin-responsive enhancer system. Proc. Natl Acad. Sci. USA, 83, 2802-2806.
22. KAWAI S AND NISHIZAWA M. (1984). New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol. Cell Biol., 4, 1172-1174.
23. KAWAJIRI K AND FUJIIKURIYAMA Y. (1991). P450 and human cancer. Jpn. J. Cancer Res., 82, 1325-1335.
24. KELLERMANN G, SHAW CR AND LUYTEN-KELLERMANN M. (1973). Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med., 189, 934-937.
25. KELSEY KT, WIENCKE JK AND SPITZ MR. (1994). A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans. Carcinogenesis, 15, 1121-1124.
26. KUMAR V, GREEN S, STACK G, BERRY M, JIN J AND CHAMBON P. (1987). Functional domains of the human estrogen receptor. Cell, 51, 941-951.
27. LUSSKA A, WU L AND WHITLOCK JP, JR. (1992). Superinduction of CYP1A1 transcription by cycloheximide: role of the DNA binding site for the liganded Ah receptor. J. Biol. Chem., 267, 15146-15151.
28. MANIATIS T, FRITSCH EF AND SAMBROOK J. (1982). Molecular Cloning: A Laboratory Manual. pp. 187-210. Cold Spring Harbor Press: Cold Spring Harbor, NY.
29. MOORE M, NARASIMHAN TR, STEINBERG M, WANG X AND SAFE S. (1993). Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate. Arch. Biochem. Biophys., 305, 483-488.
30. MORGAN TL, MAHER VM AND MCCORMICK JJ. (1986). Optimal parameters for the polybrene-induced DNA transfection of diploid human fibroblasts. In Vitro Cell Dev. Biol., 22, 317-319.
31. MURRAY GI, FOSTER CO, BARNES TS, WEAVER RJ, EWEN SWB, MELVIN WT AND BURKE MD. (1991). Expression of cytochrome P4501A in breast cancer. Br. J. Cancer, 63, 1021-1023.
32. NAKACHI K, IMAI K, HAYASHI S AND KAWAJIRI K. (1993). Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53, 2994-2999.
33. NELSON DR, KAMATAKI T, WAXMAN DJ, GUENGERICH FP, ESTABROOK RW, FEYEREISEN R, GONZALEZ FJ, COON MJ, GUNSALUS IC, GOTOH O, OKUDA K AND NEBERT DW. (1993). The P450 Superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes and nomenclature. DNA Cell Biol., 12, 1-51.
34. NEMOTO N AND SAKURAI J. (1991). Increase of CYP1A1 mRNA and AHH activity by inhibitors of either protein or RNA synthesis in mouse hepatocytes in primary culture. Carcinogenesis, 12, 2115-2121.
35. PASANEN M, STACEY S, LYKKESFELDT A, BRIAND P, HINES R AND AUTRUP H. (1988). Induction of cytochrome P-4501A1 gene expression in human breast tumor cells. Chem.-Biol. Interact., 66, 223-232.
36. PYYKKÖ K, TUIMALA R, AALTO L AND PERKIÖ T. (1991). Is aryl hydrocarbon hydroxylase activity a new prognostic indicator for breast cancer. Br. J. Cancer, 63, 596-600.
37. REICK M, ROBERTSON RW, PASCO DS AND FAGAN JB (1994). Down-regulation of nuclear aryl hydrocarbon receptor DNA-binding and transactivation functions: requirement for a labile or inducible factor. Mol. Cell Biol., 14, 5653-5660.
38. REYES H, REISZ-PORSZASZ S AND HANKINSON O. (1992). Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science, 256, 1193-1195.
39. ROBERTSON RW, ZHANG L, PASCO DS AND FAGAN JB. (1994). Aryl hydrocarbon-induced interactions at multiple DNA elements of diverse sequence a multicomponent mechanism for activation of cytochrome P4501A1 (CYP1A1) gene transcription. Nucleic Acids Res., 22, 1741-1749.
40. SIVARAMAN L, LEATHAM MP, YEE J, WILKENS LR, LAU AF AND LE MARCHAND L. (1994). CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res., 54, 3692-3695.
41. STERLING K, WEAVER J, HO KL, XU LC AND BRESNICK E. (1993). Rat CYP1A1 negative regulatory element: biological activity and interaction with a protein from liver and hepatoma cells. Mol. Pharmacol., 44,560-568.
42. SWANSON HI AND BRADFIELD CA. (1993). The Ah-receptor: genetics, structure and function. Pharmacogenetics, 3, 213-223.
43. TAIOLI E, CROFTS F, TRACKMAN J, DEMOPOULOS R, TONIOLO P AND GARTE SJ. (1995). A specific African American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Res., 55, 472-473.
44. THOMSEN JS, NISSEN L, STACEY SN, HINES RN AND AUTRUP H. (1991). Differences in 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible CYP1A1 expression in human breast carcinoma cell lines involve altered transacting factors. Eur. J. Biochem., 197, 577-582.
45. THOMSEN JS, WANG X, HINES RN AND SAFE S. (1994). Restoration of Ah responsiveness in MDA-MB-231 human breast cancer cells by transient expression of the estrogen receptor. Carcinogenesis, 15, 933-937.
46. VICKERS PJ, DUFRESNE MJ AND COWAN KH. (1989). Relation between cytochrome P4501A1 expression and estrogen receptor content of human breast cancer cells. Mol. Endocrinol., 3, 157-164.
47. VILLA E, CAMELLINI L, DUGANI A, ZUCCHI F, GROTTOLA A, MERIGHI A, BUTTAFOCO P, LOSI L AND MANENTI F. (1995). Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma. Cancer Res., 55, 498-500.
48. WANG X, ROSENGREN R, MORRISON V AND SAFE S. (1992). Characterization of the aryl hydrocarbon receptor in the human C-4II cervical squamous carcinoma cell line. Biochem. Pharmacol., 43, 1635-1642.
49. WANG X, PORTER W, KRISHNAN V, NARASIMHAN TR AND SAFE S. (1993). Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated decrease of the nuclear estrogen receptor in MCF-7 human breast cancer cells. Mol. Cell. Endocrinol., 96, 159-166.
50. WATSON AJ, WEIR-BROWN KI, BANNISTER RM, CHU F, REISZ-PORSZASZ S, FUJII-KURIYAMA Y, SOGAWA K AND HANKINSON O. (1992). Mechanism of action of a repressor of dioxin-dependent induction of Cyp1a1 gene transcription. Mol. Cell Biol., 12, 2115-2123.
51. WHITELAW M, PONGRATZ I, WILHELMSSON A, GUSTAFSSON JA AND POELLINGER L. (1993). Ligand-dependent recruitment of the arnt coregulator determines DNA recognition by the dioxin receptor. Mol. Cell Biol., 13, 2504-2514.
52. WHITLOCK JP, JR. (1993). Mechanistic aspects of dioxin action. Chem. Res. Toxicol., 6, 754-763.